BRNS
Price
$0.99
Change
+$0.01 (+1.01%)
Updated
Jun 6 closing price
Capitalization
39.94M
60 days until earnings call
SLN
Price
$5.44
Change
+$0.03 (+0.55%)
Updated
Jun 6 closing price
Capitalization
225.29M
Interact to see
Advertisement

BRNS vs SLN

Header iconBRNS vs SLN Comparison
Open Charts BRNS vs SLNBanner chart's image
Barinthus Biotherapeutics
Price$0.99
Change+$0.01 (+1.01%)
Volume$4.64K
Capitalization39.94M
Silence Therapeutics
Price$5.44
Change+$0.03 (+0.55%)
Volume$213.96K
Capitalization225.29M
BRNS vs SLN Comparison Chart
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. SLN commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Buy and SLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (BRNS: $0.86 vs. SLN: $5.19)
Brand notoriety: BRNS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 161% vs. SLN: 47%
Market capitalization -- BRNS: $39.94M vs. SLN: $225.29M
BRNS [@Biotechnology] is valued at $39.94M. SLN’s [@Biotechnology] market capitalization is $225.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, BRNS is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 4 bullish, 6 bearish.
  • SLN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLN is a better buy in the short-term than BRNS.

Price Growth

BRNS (@Biotechnology) experienced а +3.61% price change this week, while SLN (@Biotechnology) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($225M) has a higher market cap than BRNS($39.9M). SLN YTD gains are higher at: -24.564 vs. BRNS (-28.891). SLN has higher annual earnings (EBITDA): -48.99M vs. BRNS (-55.37M). SLN has more cash in the bank: 147M vs. BRNS (111M). SLN has less debt than BRNS: SLN (117K) vs BRNS (12M). SLN has higher revenues than BRNS: SLN (43.3M) vs BRNS (15M).
BRNSSLNBRNS / SLN
Capitalization39.9M225M18%
EBITDA-55.37M-48.99M113%
Gain YTD-28.891-24.564118%
P/E RatioN/AN/A-
Revenue15M43.3M35%
Total Cash111M147M76%
Total Debt12M117K10,256%
TECHNICAL ANALYSIS
Technical Analysis
BRNSSLN
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 20 days ago
89%
Declines
ODDS (%)
Bearish Trend 18 days ago
87%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
84%
Bearish Trend 12 days ago
80%
Aroon
ODDS (%)
Bullish Trend 12 days ago
67%
Bullish Trend 12 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
+3.49%
NGNE - BRNS
51%
Loosely correlated
+3.34%
CRNX - BRNS
26%
Poorly correlated
+1.39%
SLN - BRNS
25%
Poorly correlated
+3.80%
BPTSY - BRNS
25%
Poorly correlated
N/A
PDSB - BRNS
24%
Poorly correlated
-4.20%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+3.80%
CLLS - SLN
43%
Loosely correlated
-3.42%
NGNE - SLN
38%
Loosely correlated
+3.34%
RCKT - SLN
36%
Loosely correlated
+6.44%
IDYA - SLN
36%
Loosely correlated
+0.72%
GBIO - SLN
36%
Loosely correlated
-1.11%
More